Source:http://linkedlifedata.com/resource/pubmed/id/10782693
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
2000-6-20
|
pubmed:abstractText |
A series of novel 6-O-substituted erythromycin A derivatives has been synthesized. Good in vitro antibacterial activity has been demonstrated for analogues incorporating a variety of structural features. The methodology disclosed is expected to find application in the design of future macrolide antibiotics that target the prevalent bacterial resistance problem.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0960-894X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
17
|
pubmed:volume |
10
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
815-9
|
pubmed:dateRevised |
2000-12-18
|
pubmed:meshHeading | |
pubmed:year |
2000
|
pubmed:articleTitle |
Synthesis and antibacterial activity of novel 6-O-substituted erythromycin A derivatives.
|
pubmed:affiliation |
Infectious Diseases Research, Abbott Laboratories, Abbott Park, IL 60064-3537, USA. rick.f.clark@abbott.com
|
pubmed:publicationType |
Journal Article
|